Significant Ownership of Orca Capital AG

Signature - Title
/s/ Thomas Konig - Thomas Konig/Director
Location
Pfaffenhofen, Germany
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Orca Capital AG.

Follow Filing Activity

Follow Orca Capital AG and return when a new Schedule 13D/G filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Significant Ownership of Orca Capital AG

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SLXN Silexion Therapeutics Corp Ordinary Shares, par value $0.0135 per share 4.9% $802,137 109,432 Orca Capital AG 11 Sep 2025
PHIO Phio Pharmaceuticals Corp. Common Stock, par value $0.0001 per share 4.9% $770,351 -$231,251 538,707 -23% Orca Capital AG 08 Dec 2025
PPBT Purple Biotech Ltd. American Depositary Shares, each representing 200 Ordinary Shares 4.9% $652,619 306,394 Orca Capital AG 04 Sep 2025
KTTA Pasithea Therapeutics Corp. Common Stock, par value $0.0001 per share 4.9% $613,228 -$14,002 362,857 -2.2% Orca Capital AG 07 May 2025
SXTP 60 Degrees Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 4.9% $382,327 166,229 Orca Capital AG 15 Jul 2025
VERO Venus Concept Inc. Common Stock, par value $0.001 per share 4.9% $253,353 +$253,353 101,748 Orca Capital AG 06 Jun 2025
ENVB Enveric Biosciences, Inc. Common Stock, par value $0.01 per share 4.9% $32,016 -$22,984 97,019 -42% Orca Capital AG 31 Jan 2025
ATON AlphaTON Capital Corp Ordinary Shares, no par value 4.5% $400,000 -$481,250 640,000 -55% Orca Capital AG 28 Jan 2026
LIXT Lixte Biotechnology Holdings, Inc. Common Stock, par value $0.0001 per share 4.5% $157,216 -$127,568 120,012 -45% Orca Capital AG 14 Feb 2025
RANI Rani Therapeutics Holdings, Inc. Class A Common Stock, par value $0.0001 per share 4.3% $972,105 -$1,265,416 1,891,623 -57% Orca Capital AG 22 Jul 2025
CANF Can-Fite BioPharma Ltd. Ordinary Shares, no par value 4.1% $188,859,240 -$261,140,760 157,382,700 -58% Orca Capital AG 22 Apr 2025
CODX Co-Diagnostics, Inc. Common Stock, par value $0.001 per share 3.7% $818,338 +$19,827 2,248,182 +2.5% Orca Capital AG 28 Oct 2025
DWTX Dogwood Therapeutics, Inc. Common Stock, par value $0.0001 per share 3.7% $390,299 -$256,967 69,821 -40% Orca Capital AG 14 Mar 2025
SPCB SuperCom Ltd. Ordinary Shares, par value NIS 50 3.6% $749,990 -$891,827 124,583 -54% Orca Capital AG 31 Jan 2025
DCX Digital Currency X Technology Inc. Ordinary Shares, par value US$0.3 0.6% $121,139 -$316,146 121,139 -72% Orca Capital AG 31 Dec 2025
HCTI Healthcare Triangle, Inc. Common Stock, par value $0.00001 per share 0.2% $14,699 -$607,501 2,033 -98% Orca Capital AG 04 Mar 2026
SGLY Singularity Future Technology Ltd. Common Stock, no par value 0% $0 -$191,334 0 -100% Orca Capital AG 31 Jan 2025
SGN Signing Day Sports, Inc. Common Stock, par value $0.0001 per share 0% $0 -$1,522,460 0 -100% Orca Capital AG 20 Jan 2026
BHAT Blue Hat Interactive Entertainment Technology Ordinary Shares, par value $0.01 per share 0% $0 -$248,400 0 -100% Orca Capital AG 13 Jan 2025

Schedules 13D/G Reported by Orca Capital AG:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .